A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1)
Clinical trial NCT01586624 · COMPLETED
Trial details
- NCT number
- NCT01586624
- Sponsor
- Cancer Research UK
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-10
- Primary completion
- 2020-06-11
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.